(1) A processor may only use a non-cannabis additive in an inhalable cannabinoid product if the non-cannabis additive is accompanied by a list of ingredients from the manufacturer of the non-cannabis additive that:
- (a) In a header section, displays the name of the non-cannabis additive and the business name of the manufacturer of the non-cannabis additive;
- (b) In clear and legible font, includes a statement that the non-cannabis additive is for use in a product intended for human inhalation;
- (c) Accurately identifies all ingredients in the non-cannabis additive; and
(d) For each ingredient of the non-cannabis additive, includes:
- (A) A Chemical Abstracts Service Reference Number that specifies the ingredient’s isomer and, if applicable, enantiomer; and
- (B) The ingredient’s concentration range within 20 percentage points.
(2) A processor may not use a non-cannabis additive in an inhalable cannabinoid product that contains any amount of:
- (a) Squalene;
- (b) Squalane;
- (c) Vitamin E Acetate;
- (d) Triglycerides, including but not limited to Medium-Chain Triglyceride (MCT) Oil; or
- (e) Propylene Glycol, unless the product is going to be delivered through a metered dose inhaler whose functionality does not require combustion or heated vaporization.
- (3) On or after April 1, 2021, a processor may not manufacture or process an inhalable cannabinoid product that does not meet the requirements of this rule.
- (4) On or after July 1, 2021, a processor may not possess, sell, deliver, transfer, transport, purchase, or receive an inhalable cannabinoid product that does not meet the requirements of this rule.
(5) Sanction.
- (a) An intentional violation of this rule is a Category II violation.
- (b) An unintentional violation of this rule is a Category III violation.
Statutory/Other Authority
ORS 475C.017, 475C.233 & 475C.237
Statutes/Other Implemented
ORS 475C.017
History
OLCC 112-2022, minor correction filed 03/25/2022, effective 03/25/2022
OLCC 24-2020, adopt filed 12/21/2020, effective 12/22/2020